Keep up-to-date with the latest access to medicines news and research, plus interviews and opinion from our partners and other experts, and videos and photo stories of our work.
Chronology of access to medicine campaign in ThailandNews
The fight for access to medicines in Thailand centers around the use of compulsory licensing on three drugs. The chronology on...
How to reach 90-90-90 in UkraineNews
Today, 3 December 2015, the All-Ukrainian Network of People Living with HIV (the Network) hosted a roundtable meeting to explore...
Defending Argentina’s public health from unmerited patentsNews
Fundación Grupo Efecto Positivo defends Argentina’s public health from the abusive patents by multinational pharmaceutical companies. Fundación Grupo Efecto Positivo...
Breaking the Vicious Cycle of FearNews
This article highlights role of the US and major pharmaceutical companies to undermine trade agreements, intended to protect national interests and public health.
UNAIDS “4th 90”: Affordability of MedicinesNews
UNAIDS has seen Argentina’s proposal to add a 4th “90” to its 90-90-90 strategy as a model to be implemented...
Argentine Government Buys Generic Version of HIV DrugNews
Civil society clear way for generic version of critical HIV medicine into Argentine health system Fundación Grupo Efecto Positivo (FGEP)...
Patent opposition for Sofosbuvir requested in ArgentinaNews
Organizations of people with hepatitis C are challenging a patent application that, if successful, would prevent 800,000 people having access to treatment in Argentina.
Opportunities to Overcome Patent Barriers in UkraineNews
The All-Ukrainian Network of People Living with HIV brought together representatives from Indian and Ukrainian generic drug manufacturers to discuss...
Making HIV treatment affordable in middle-income countriesNews
Six partners meet to launch new project On 24-26 February 2015, the International Treatment Preparedness Coalition (ITPC) and its partners...
The campaign for use of compulsory licensing in ThailandNews
After eight long years of lobbying, the Thai government issued compulsory licenses for two antiretroviral drugs, Efavirenz and lopinavir/ritonavir (Kaletra)...